“Assessment of Pentraxin 3 (PTX3) and Sclerostin (SOST) Levels in Serum of Patients with Chronic Kidney Disease”, MLU, vol. 21, no. 2, pp. 1274–1280, Mar. 2021, doi: 10.37506/mlu.v21i2.2866.